Product Program year 2025 Source: CMS Open Payments

Clinical Trial Product

Device Clinical Trial Product_CRM

Open in the dashboard

General payments

$272,763

340 payments

Research payments

$15,455,776

2,217 payments

Through program year 2025, $272,763 in general payments and $15,455,776 in research payments were reported against Clinical Trial Product (Clinical Trial Product_CRM).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $261,157 260
2025 Research $6,024,098 948
2024 Research $9,390,146 1,246
2022 General $11,606 80
2022 Research $41,532 23

Breakdown

Who paid General payments · program years 2022–2025
  1. Boston Scientific Corporation $272,763 340 payments
Top recipients General payments · program year 2025
  1. Suneet Mittal Clinical Cardiac Electrophysiology · Paramus, NJ $24,043 9% · 18 payments
  2. Dina Sparano Clinical Cardiac Electrophysiology · Mayfield Heights, OH $22,713 9% · 12 payments
  3. Teresa De Marco Advanced Heart Failure and Transplant Cardiology · San Francisco, CA $18,725 7% · 12 payments
  4. James Heywood Advanced Heart Failure and Transplant Cardiology · La Jolla, CA $17,825 7% · 10 payments
  5. Jeanne Poole Clinical Cardiac Electrophysiology · Seattle, WA $16,038 6% · 8 payments

The top 5 of 96 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $151,583 58% · 57 practitioners
  2. Advanced Heart Failure and Transplant Cardiology Internal Medicine $48,602 19% · 5 practitioners
  3. Cardiovascular Disease Internal Medicine $20,608 8% · 17 practitioners
  4. Neurology Psychiatry & Neurology $15,438 6% · 2 practitioners
  5. Neurological Surgery $13,188 5% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $70,574 27% · 8 recipients
  2. Ohio $29,879 11% · 6 recipients
  3. Minnesota $28,313 11% · 6 recipients
  4. New Jersey $24,043 9% · 1 recipient
  5. New York $20,307 8% · 5 recipients

The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

340 general · 2,217 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record